Effect of Zeyin pill on cell apoptosis in mice with non-alcoholic fatty liver disease and its possible mechanism
10.3760/cma.j.cn431274-20231222-00706
- VernacularTitle:泽茵丸对非酒精性脂肪性肝病小鼠细胞凋亡的影响及其机制
- Author:
Jingzhuo LI
1
;
Jinyu HE
;
Miaoqing YE
;
Jiaojiao LIU
Author Information
1. 陕西省中医医院急诊科，西安 710003
- Keywords:
Non-alcoholic fatty liver disease;
Zeyin pill;
Dipeptidyl peptidase 4;
NF-kappa B;
Apoptosis
- From:
Journal of Chinese Physician
2024;26(9):1350-1355
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the effect of Zeyin pill on cell apoptosis in mice with non-alcoholic fatty liver disease (NAFLD) and its possible mechanism.Methods:A total of 36 mice were fed with high-fat diet for 12 weeks to establish a NAFLD model, and were randomly divided into NAFLD group, experimental group A, and experimental group B, with 12 mice in each group. Another 10 mice were fed with regular feed and included in the control group. Experimental groups A and B were orally administered with concentrated Zeyin pill at doses of 2.25 and 4.5 g/kg, respectively, once a day. The control group and the NAFLD group were given equal volume saline by gavage, and were intervened continuously for 4 weeks. Serum fasting blood glucose (FBG), insulin, dipeptidyl peptidase-4 (DPP4) enzyme activity, and oral glucose tolerance test (OGTT) results of four groups were compared; Four groups were compared in terms of liver index, total cholesterol (TC), and triglyceride (TG) content in liver tissue; The apoptosis rate of four groups of liver tissue cells was detected by TdT-mediated dUTP nick end labeling (Tunel) staining method; Oil red O staining was used to observe lipid deposition in four groups of liver tissues; Protein immunoblotting was used to detect the protein expression of DPP4, nuclear transcription factor kappa B (NF-κB) p65, p-NF-κB p65, and caspase-3 in liver tissue.Results:The blood glucose levels in the NAFLD group were higher than those in the control group at 30, 60, and 120 minutes after FBG and OGTT (all P<0.05); The blood glucose levels in groups A and B after FBG and OGTT were lower than those in the NAFLD group at 30, 60, and 120 minutes (all P<0.05); The blood glucose levels in group B were lower than those in group A at 30, 60, and 120 minutes after FBG and OGTT (all P<0.05). The insulin and DPP4 enzyme activities, liver index, liver tissue TC and TG content, and liver cell apoptosis rate in the NAFLD group were all higher than those in the control group (all P<0.05); The insulin and DPP4 enzyme activities, liver index, liver tissue TC and TG content, and liver cell apoptosis rate in groups A and B were all lower than those in the NAFLD group (all P<0.05); The insulin and DPP4 enzyme activities, liver index, liver tissue TC and TG content, and liver cell apoptosis rate in experimental group B were all lower than those in experimental group A (all P<0.05). The Oil Red O staining results showed that there was no significant lipid deposition in the control group, while the NAFLD group exhibited diffuse distribution of orange red lipid droplets and large vesicular steatosis. The number of orange red lipid droplets in the liver tissue of experimental groups A and B was less than that of the NAFLD group, and the number of orange red lipid droplets in experimental group B was less than that of experimental group A. The results of protein immunoblotting showed that the expression levels of DPP4, Caspase-3 proteins and p-NF-κB p65/NF-κB p65 in liver tissue of NAFLD group were higher than those of the control group (all P<0.05); The expression levels of DPP4 and Caspase-3 proteins, as well as p-NF-κB p65/NF-κB p65, in the liver tissues of groups A and B were lower than those in the NAFLD group (all P<0.05); The expression levels of DPP4 and Caspase-3 proteins, as well as p-NF-κB p65/NF-κB p65, in the liver tissue of experimental group B were lower than those in experimental group A (all P<0.05). Conclusions:Zeyin Pill can lower blood glucose levels, reduce liver cell apoptosis and lipid deposition in NAFLD mice, possibly by inhibiting the DPP4/NF-κB signaling pathway.
